Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Arnold

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 16, 2026
Association between aldehyde dehydrogenase 4 family member A1 plasma concentrations and atherosclerotic disease in patients with ischemic stroke: Results from the prospective multicenter BIOSIGNAL studyTolga D Dittrich, Annaelle V Zietz, Markus Arnold, et al.
European Stroke Journal|September 8, 2025
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort studyJohannes Frenger, Benjamin Jeker, Markus Arnold, et al.
European Stroke Journal|January 30, 2026
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort studyJohannes Frenger, Benjamin Jeker, Markus Arnold, et al.
Stroke|October 31, 2024
Interleukin-6, C-Reactive Protein, and Recurrence After Stroke: A Time-Course Analysis of Individual-Participant DataJohn J McCabe, Cathal Walsh, Sarah Gorey, et al.
Stroke|July 18, 2025
Interleukin-6, C-Reactive Protein, and Vascular Recurrence After Stroke With and Without AtherosclerosisJohn J McCabe, Katie Harris, Cathal Walsh, et al.
Neurology|July 1, 2024
Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort StudiesAlan C Cameron, Markus Arnold, Georgios Katsas, et al.
Neurology|February 16, 2026
Systemic Inflammation and Recurrence After Atrial Fibrillation-Related Stroke: An Individual Participant Data Meta-AnalysisJohn J McCabe, Katie Harris, Sarah Gorey, et al.
Stroke|April 21, 2025
Role of NT-proBNP for Atrial Fibrillation Detection After Ischemic Stroke: A Time-Dependent RelationshipIsra Hatab, Markus Kneihsl, Markus Arnold, et al.
European Stroke Journal|April 6, 2023
Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic strokeTim Honegger, Juliane Schweizer, Antonela Bicvic, et al.
European Heart Journal|March 12, 2021
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL studyMarkus Arnold, Juliane Schweizer, Christos T Nakas, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 16, 2026
Association between aldehyde dehydrogenase 4 family member A1 plasma concentrations and atherosclerotic disease in patients with ischemic stroke: Results from the prospective multicenter BIOSIGNAL studyTolga D Dittrich, Annaelle V Zietz, Markus Arnold, et al.
European Stroke Journal|September 8, 2025
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort studyJohannes Frenger, Benjamin Jeker, Markus Arnold, et al.
European Stroke Journal|January 30, 2026
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort studyJohannes Frenger, Benjamin Jeker, Markus Arnold, et al.
Stroke|October 31, 2024
Interleukin-6, C-Reactive Protein, and Recurrence After Stroke: A Time-Course Analysis of Individual-Participant DataJohn J McCabe, Cathal Walsh, Sarah Gorey, et al.
Stroke|July 18, 2025
Interleukin-6, C-Reactive Protein, and Vascular Recurrence After Stroke With and Without AtherosclerosisJohn J McCabe, Katie Harris, Cathal Walsh, et al.
Neurology|July 1, 2024
Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort StudiesAlan C Cameron, Markus Arnold, Georgios Katsas, et al.
Neurology|February 16, 2026
Systemic Inflammation and Recurrence After Atrial Fibrillation-Related Stroke: An Individual Participant Data Meta-AnalysisJohn J McCabe, Katie Harris, Sarah Gorey, et al.
Stroke|April 21, 2025
Role of NT-proBNP for Atrial Fibrillation Detection After Ischemic Stroke: A Time-Dependent RelationshipIsra Hatab, Markus Kneihsl, Markus Arnold, et al.
European Stroke Journal|April 6, 2023
Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic strokeTim Honegger, Juliane Schweizer, Antonela Bicvic, et al.
European Heart Journal|March 12, 2021
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL studyMarkus Arnold, Juliane Schweizer, Christos T Nakas, et al.
Pageof 4